Literature DB >> 8609717

The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation.

J E Rasko1, D Metcalf, M T Rossner, C G Begley, N A Nicola.   

Abstract

In this study the distribution and quantitation of the flt3/flk-2 receptor was examined on bone marrow cells and defined haemopoietic subpopulations. Undifferentiated cells expressed the greatest numbers of flt3/flk-2 receptors: 19% of primitive lin-kit+sca-1+ bone marrow cells and 16% of fetal liver lin-aa4.1+ cells exhibited over 15 000 receptors per cell as determined by binding of the radiolabeled cognate ligand (flt3/flk-2 ligand, FL). Moderate binding was demonstrated on early B lymphocyte subsets (4400 receptors per cell) and very low levels were detected on monocytes. Binding was not detected on promyelocytes, myelocytes, promonocytes, metamyelocytes, polymorphonuclear cells, eosinophils or nucleated erythroid cells. FL enhanced the survival of primitive lin kit+sca-1+ cells with an efficacy s with an efficacy equivalent to stem cell factor (SCF). FL stimulated predominantly blast and granulocyte-macrophage colony formation in cultures of bone marrow cells by both direct and indirect mechanisms. Marked synergistic effects of FL with combinations of colony stimulating factors (CSFs) or interleukin-6 occurred in the proliferation of primitive lin-kit+sca-1+ cells, but not lin-kit+sca-1- progenitor cells. Surprisingly, recloning experiments revealed that FL plus IL-3 increased the generation of progenitor cells by lin-kit a-1- cells compared with SCF plus IL-3. Thus FL functions as a factor with both direct and indirect stimulatory activities directed to the expansion, maintenance of clonogenic potential, and possibly limited self-renewal, of early haemopoietic cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8609717

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  16 in total

1.  Murine hematopoietic stem cells committed to macrophage/dendritic cell formation: stimulation by Flk2-ligand with enhancement by regulators using the gp130 receptor chain.

Authors:  D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 2.  Multi-parameter fluorescence-activated cell sorting and analysis of stem and progenitor cells in myeloid malignancies.

Authors:  Britta Will; Ulrich Steidl
Journal:  Best Pract Res Clin Haematol       Date:  2010-09       Impact factor: 3.020

3.  Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus.

Authors:  A R Iyengar; C A Bonham; M A Antonysamy; V M Subbotin; A Khanna; N Murase; A S Rao; T E Starzl; A W Thomson
Journal:  Transplantation       Date:  1997-05-15       Impact factor: 4.939

4.  Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation.

Authors:  Anne Kresinsky; Tina M Schnöder; Ilse D Jacobsen; Martina Rauner; Lorenz C Hofbauer; Volker Ast; Rainer König; Bianca Hoffmann; Carl-Magnus Svensson; Marc Thilo Figge; Ingrid Hilger; Florian H Heidel; Frank- D Böhmer; Jörg P Müller
Journal:  Oncogene       Date:  2019-02-28       Impact factor: 9.867

5.  FLT3 ligand regulates thymic precursor cells and hematopoietic stem cells through interactions with CXCR4 and the marrow niche.

Authors:  Kirsten M Williams; Amber R Moore; Philip J Lucas; Juin Wang; Catherine V Bare; Ronald E Gress
Journal:  Exp Hematol       Date:  2017-05-26       Impact factor: 3.084

6.  Tyk2 is dispensable for induction of myeloproliferative disease by mutant FLT3.

Authors:  Hideaki Nakajima; Fumi Shibata; Hidetoshi Kumagai; Kazuya Shimoda; Toshio Kitamura
Journal:  Int J Hematol       Date:  2006-07       Impact factor: 2.490

7.  Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administration.

Authors:  Evert-Jan F M de Kruijf; Henny Hagoort; Gerjo A Velders; Willem E Fibbe; Melissa van Pel
Journal:  Haematologica       Date:  2010-01-15       Impact factor: 9.941

8.  In vivo evidence for an instructive role of fms-like tyrosine kinase-3 (FLT3) ligand in hematopoietic development.

Authors:  Panagiotis Tsapogas; Lee Kim Swee; Anja Nusser; Natko Nuber; Matthias Kreuzaler; Giuseppina Capoferri; Hannie Rolink; Rhodri Ceredig; Antonius Rolink
Journal:  Haematologica       Date:  2014-01-24       Impact factor: 9.941

9.  Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion.

Authors:  Noemí Sevilla; Dorian B McGavern; Chao Teng; Stefan Kunz; Michael B A Oldstone
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

10.  FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia.

Authors:  Benjamin H Lee; Zuzana Tothova; Ross L Levine; Kristina Anderson; Natalija Buza-Vidas; Dana E Cullen; Elizabeth P McDowell; Jennifer Adelsperger; Stefan Fröhling; Brian J P Huntly; Miloslav Beran; Sten Eirik Jacobsen; D Gary Gilliland
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.